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Cardiovascular risk factors in relatives of type 2
diabetics with normal glucose tolerance test
and elevated one-hour plasma glucose
Czynniki ryzyka chorób sercowo-naczyniowych u krewnych osób chorujących
na cukrzycę typu 2 z prawidłowym testem tolerancji glukozy i zwiększonym
stężeniem glukozy w pierwszej godzinie po obciążeniu
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Abstract
Introduction: To investigate the effect of elevated one hour post-load plasma glucose on cardiovascular risk factors, in normal glucose
tolerance (NGT) people, who are first degree relatives of type 2 diabetics.
Material and methods: A cross-sectional study on 1475 NGT subjects (Arian ethnicity), who had one hour post-load plasma glucose was
carried out. We compared the mean of age, sex, body mass index, waist circumference, blood pressure, lipid profile, and area under the
curve of glucose (AUC-G) of 1190 out of 1475 NGT subjects with one hour plasma glucose (1hpG) ≥ 155 mg/dL, and 285 NGT subjects with
1hpG < 155 mg/dL.
Results: The mean age, body mass index, waist circumference, blood pressure, lipid profile (but not low HDL-cholesterol), and area under
the curve of glucose (AUC-G) was significantly higher in NGT subjects with 1hpG ≥ 155 mg/dL (P < 0.05). Normal glucose tolerance
people (first degree relatives of type 2 diabetic patients) with 1hpG ≥ 155 mg/dL were older and heavier than those with 1hpG < 155 mg/dL.
Cardiovascular risk factors (but not low HDL and hypertension) were more prevalent in those with elevated one hour post-load group
(P < 0.05).
Conclusions: NGT subjects with elevated one hour post-load plasma glucose (1hpG ≥ 155 mg/dL) had higher prevalence of most cardio-
vascular risk factors in comparison with those with 1hpG < 155 mg/dL. (Pol J Endocrinol 2010; 61 (4): 359–363)
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Streszczenie
Wstęp: Celem badania była ocena wpływu podwyższonej glikemii w pierwszej godzinie po obciążeniu glukozą na czynniki ryzyka serco-
wo-naczyniowego u osób z prawidłową tolerancją glukozy (NGT, normal glucose tolerance) będących krewnymi pierwszego stopnia cho-
rych na cukrzycę typu 2.
Materiał i metody: Badanie wieloośrodkowe objęło 1475 osób z prawidłową tolerancją glikemii (etniczni Arianie), u których oznaczono
stężenie glukozy w osoczu w godzinę po doustnym obciążeniu glukozą. Wszystkich chorych podzielono na dwie grupy w zależności od
wartości glikemii: 1190, u których glikemia 1 godzinę po obciążeniu glukozą wynosiła ≥ 155 mg/dl i 285 osób < 155 mg/dl. W obu grupach
porównano średnie wartości następujących parametrów: wieku, płci, wskaźnika masy ciała, obwodu talii, ciśnienia tętniczego, profilu
lipidowego i pola pod krzywą stężenia glukozy.
Wyniki: U osób z prawidłową tolerancją glikemii (będących krewnymi pierwszego stopnia chorych na cukrzycę typu 2), u których glike-
mia na czczo w godzinę po doustnym obciążeniu glukozą wynosiła ≥ 155 mg/dl (p < 0,05) stwierdzono istotnie wyższe wartości następu-
jących parametrów: średni wiek, wskaźnik masy ciała, obwód talii, ciśnienie tętnicze, stężenia lipidów (z wyjątkiem cholesterolu frakcji
HDL) i pola pod krzywą stężenia glukozy. Osoby, u których glikemia w godzinę po obciążeniu glukozą wynosiła ≥ 155 mg/dl były starsze
i cięższe niż osoby z niższym poposiłkowym stężeniem glukozy (< 155 mg/dl). Czynniki ryzyka sercowo-naczyniowego (z wyjątkiem
niskiego stężenia cholesterolu frakcji HDL i nadciśnienia tętniczego) występowały częściej u osób z wyższymi wartościami glikemii w godzi-
nę po obciążeniu glukozą (p < 0,05).
Wnioski: U osób z prawidłową tolerancją glukozy i wyższymi wartościami glikemii w godzinę po obciążeniu glukozą (≥ 155 mg/dl)
stwierdzono częstsze występowanie czynników ryzyka chorób sercowo-naczyniowego niż u osób, u których glikemia w godzinę po
obciążeniu glukozą wynosiła < 155 mg/dl. (Endokrynol Pol 2010; 61 (4): 359–363)
Słowa kluczowe: cukrzyca typu 2, test tolerancji glukozy, czynniki ryzyka
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The number of type 2 diabetic patients is expected to
increase to ~300 million by the year 2025, in compari-
son with 150 million diabetics in the year 2000 [1].
Type 2 diabetes mellitus (T2DM), as a chronic dis-
ease, not only causes serious morbidity and mortality
due to vascular complications but also imposes a heavy
economic burden on countries [2].
Changes in lifestyle and drug therapy decrease the
incidence of T2DM in high-risk subjects. Therefore, it is
essential to identify the high-risk people to establish
a successful primary prevention program for T2DM [3–5].
Among the high-risk subjects for T2DM and related
cardiovascular complications are people with impaired
glucose tolerance (IGT) test [6]. However, some longi-
tudinal epidemiological surveys show that ~40% of
subjects with T2DM have normal glucose tolerance
(NGT) test at baseline [7]. Therefore, it is necessary to
investigate which category of normal glucose tolerance
people is at high risk of developing T2DM [6].
Recently, some studies have demonstrated that ele-
vated one-hour plasma glucose levels (1hPG) during
oral glucose tolerance test (OGTT) are a suitable pre-
dictor for the development of type 2 diabetes in future
[2, 8], and NGT subjects with 1hPG at or above 155 mg/dl
are at high-risk of T2DM development [8–10].
Also, one study has demonstrated that NGT subjects
with elevated 1hPG develop early atherosclerosis in the
carotid artery as a sign of cardiovascular atherosclerosis [6].
Meanwhile, another study has shown that in NGT
subjects with 1hPG ≥ 155 mg/dL, cardiovascular risk
factors are more prevalent in comparison with 1hPG
< 155 mg/dL NGT subjects [11].
Based on these results, the aim of our study was to
compare the demographic characteristics and cardiovas-
cular risk factors in NGT subjects with 1hPG ≥ 155 mg/dL
and those with 1hPG < 155 mg/dL who are first degree
relatives of T2DM patients.
Material and methods
From 2005 to 2008, of 2952 people (Arian ethnicity) who
were first degree relatives of type 2 diabetics, 1526 indi-
viduals (1140 females, 386 males) had normal glucose
tolerance test based on two-hour plasma glucose less
than 140 mg/dL and fasting plasma glucose less than
100 mg/dL [12]. Of these 1526 NGT participants, one-
-hour plasma glucose concentration was measured in
1475 people. Participants were 30–55 years old and were
first degree relatives of T2DM patients who had already
been registered at the Isfahan Endocrine and Metabo-
lism Research Centre (IEMRC). After 10 hours of over-
night fasting, oral glucose tolerance test (OGTT) with
75 g glucose was performed. Plasma glucose was mea-
sured at 0, 30, 60, and 120 minutes. Then, according to
American Diabetes Association (ADA) criteria [12], the
subjects were divided into prediabetics (n = 1140), nor-
mal glucose tolerant (NGT) (n = 1526), and diabetics
(n = 284). Prediabetics and diabetic patients were ex-
cluded from the study. People with normal glucose tol-
erance test were divided into two groups, one with
1hPG ≥ 155 mg/dL (n = 1190) and the other with 1hPG
BS < 155 mg/dL (n = 285).
Plasma glucose was measured with GOD-PAP meth-
od (by BT 3000 PLUS autoanalyzer, Italy).
All participants signed a written consent form to
enrol in the study. The study was designed according
to the Ethics Regulations of the Helsinki Declaration,
and its protocol was approved by the  IEMRC Medical
Ethics Committee.
Total cholesterol, HDL-cholesterol, and triglyceride
were measured at fasting state by GHOD-PAP and
GPO-PAP methods, respectively (by BT3000 autoana-
lyzer, Italy). LDL-cholesterol was calculated based on
the Friedewald formula. In our study, we defined meta-
bolic syndrome according to ATP ²²² criteria [13].
Demographic and anthropometric characteristics
(age, sex, weight, height, waist circumference) and blood
pressure were measured for all participants. Body mass
index (BMI) was calculated by body weight (kg)/height
(m2). Blood pressure was measured after 15 minutes of
rest in a seated position with a standard mercury sphyg-
momanometer (ALPK2, Japan) and recorded in mmHg.
Statistical analysis
Data are shown as mean (SD). Student’s t -test was used
to compare quantitative variables (cholesterol, triglyc-
eride, HDL-c, LDL-c, blood pressure, waist, BMI, age,
area under the curve of mean plasma glucose (AUC-G)
during OGTT, and Chi square test was used to com-
pare the qualitative variable (sex) between two groups
(NGT subjects, with 1hPG ≥ 155 mg/dL and 1hPG
< 155 mg/dL). To know the effect of one hour plasma
glucose level on the coronary heart disease risk factors
(BMI ≥ 25 kg/m2, cholesterol ≥ 200 mg/dL, HDL
£ 40 mg/dl in men or HDL £ 50 mg/dL in women,
LDL ≥ 130 mg/dL, triglycerides ≥ 150 mg/dL, blood
pressure ≥ 140/90 mm Hg, and waist ≥ 102 cm in man
or ≥ 88 cm in women), age, sex, and BMI were adjusted
by multiple logistic regression. The area under the curve
of mean plasma glucose during OGTT was calculated
by the trapezoid rule. P values less than 0.05 were con-
sidered statistically significant.
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From 1526 participants who were first degree relatives
of T2DM, with normal glucose tolerance test , 1190 and
285 subjects, had one hour plasma glucose level (1hPG)
less than 155 mg/dL and equal or more than 155 mg/dL,
respectively.
Table I illustrates the demographic and laboratory
characteristics of normal glucose tolerance test (NGT)
individuals, with one hour plasma glucose (1hPG)
< 155 mg/dL and those with 1hPG ≥ 155 mg/dL. The mean
age, BMI, blood pressure, triglyceride, cholesterol, LDL-cho-
lesterol, waist, AUC-G, and HDL-cholesterol were signifi-
cantly higher in NGT subjects with 1hPG ≥ 155 mg/dL.
Table II shows that the mean plasma glucose in 0,
30, 60, and 120 minutes, during OGTT, in the 1hpG
≥ 155 mg/dL NGT group is significantly higher than in
the 1hpG < 155 mg/dL NGT group.
Table II also shows that the mean plasma glucose
during OGTT in NGT subjects with 1hPG ≥ 155 mg/dL
is significantly higher.
AUC-G is significantly higher in the 1hPG ≥ 155
group (Table I).
Table III illustrates the prevalence and odds ratio
(OR) of the cardiovascular risk factors by glucose cate-
gory, after adjusting for age, sex, and BMI. The preva-
lence of most ischaemic heart disease risk factors (but
low HDL and hypertension) is increased in the 1hpG
≥ 155 mg/dL group.
Discussion
This study investigates the association of one-hour post-
load plasma glucose level with cardiovascular risk fac-
tors in first degree relatives of type 2 diabetics with nor-
mal glucose tolerance test. Normal glucose tolerance
subjects with 1hPG ≥ 155 mg/dL have higher blood
pressure and more abdominal and generalized obesity.
The blood pressure difference between two groups is
not remarkable clinically; however, it is statistically sig-
nificant, probably due to the large sample size (Table I).
They were older than those with 1hPG < 155 mg/dL.
Males have a higher prevalence of 1hPG ≥ 155 mg/dL
(Table I).
In 1hPG ≥ 155 mg/dL NGT subjects, most of the car-
diovascular risk factors were significantly, more preva-
lent than those with 1hPG < 155 mg/dL (Table II).
In concordance with our study, in the GENFIEV
study [11] the prevalence of most of the cardiovascular
risk factors (but not low HDL-c) in NGT subjects
with 1hpG ≥ 155 mg/dL was higher in comparison
with 1hpG < 155 mg/dL. In another study [16], 1hPG
≥ 155 mg/dL NGT subjects had higher BMI and lipid
ratio (triglyceride/HDL and total cholesterol/HDL) and
were older, in comparison to NGT subjects with 1hPG
< 155 mg/dL. However, in one study in Japan [14], there
were no significant differences in triglyceride, total cho-
lesterol, and HDL-cholesterol levels between two NGT
groups (with or without elevated 1hpG levels).
Table I. The means of demographic and laboratory data in first degree relatives of type 2 diabetics with normal glucose
tolerance, based on one-hour post-load plasma glucose levels
Tabela I. Dane demograficzne i laboratoryjne osób z prawidłową tolerancją glikemii w zależności od poziomu glikemii
w godzinę po obciążeniu glukozą będących krewnymi chorych na cukrzycę typu 2
Data 1hpG < 155 mg/dL 1hpG ≥ 155 mg/dL P value
Number 1190 Mean (SD) Number 285 Mean (SD)
Age 1177 41.9 (6.54) 282 43.5 (6.75) 0.001
Sex
Man 289 24.3% 89 31.2% 0.017
Woman 899 75.7% 196 68.8%
BMI [kg/m2] 1175 28.3 (4.28) 280 29.4 (4.52) 0.001
 SBP [mm Hg] 1139 112 (15.4) 278 116 (18.0) 0.001
 DBP [mm Hg] 1139 72 (11.9) 278 75 (12.8) 0.001
Triglyceride [mg/dL] 1154 156.4 (97.57) 282 174 (84.2) 0.001
Cholesterol [mg/dL] 1159 191.0 (37.98) 281 204 (39.0) 0.001
HDL-cholesterol [mg/dL] 1130 45.7 (11.91) 273 45.0 (11.5) 0.38
LDL-cholesterol [mg/dL] 1089 115.1 (33.56) 269 124 (35.6) 0.001
Waist [cm] 1157 87.1 (9.56) 280 90.6 (9.9) 0.001
AUC-G [mg/h/dL] 1142 731 (99.68) 268 954 (78.29) 0.001
1hpG — one-hour post-load plasma glucose; SD — standard deviation; SBP — Systolic Blood Pressure; DBP — Diastolic Blood Pressure; AUC-G —
Area under the curve of glucose
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Table III. Prevalence of coronary heart disease risk factors in first degree relatives of type 2 diabetics with normal glucose
tolerance according to one-hour post-load plasma glucose
Tabela III. Występowanie czynników ryzyka choroby wieńcowej u krewnych pierwszego stopnia osób chorych na cukrzycę
typu 2 w zależności od glikemii 1 godzinę po obciążeniu glukozą
Cardiovascular risk factors Number Prevalence (%) OR (CI 95%)
BMI ≥ 25 kg/m2 1172
1hpG < 155 mg/dL 933 79 1
1hpG ≥ 155 mg/dL 239 85 1.5 (1.0–2.1)
Hypertension* 209
1hpG < 155 mg/dL 156 13 1
1hpG ≥ 155 mg/dL 53 19 1.1 (0.7–1.6)
Triglycerides ≥ 150 mg/dL 612
1hpG < 155 mg/dL 460 39 1
1hpG ≥ 155 mg/dL 152 53 1. 4 (1.0-1.8)
Cholesterol ≥ 200 mg/dL 591
1hpG < 155 mg/dL 439 37 1
1hpG ≥ 155 mg/dL 152 54 1.7 (1.3–2.2)
LDL-c ≥ 130 mg/dl 446
1hpG < 155 mg/dL 333 30 1
1hpG ≥ 155 mg/dL 113 42 1.4 (1.1–1.9)
HDL-c £ 40 mg/dl (male) 190
1hpG < 155 mg/dL 148 53 1
1hpG ≥ 155 mg/dL 42 51 0.97 (0.7–1.3)
HDL-c £ 50 mg/dl (female) 691
1hpG < 155 mg/dL 564 66.2 1
1hpG ≥ 155 mg/dL 127 66.5 0.97 (0.7–1.3)
Waist > 102 cm (male) 49
1hpG < 155 mg/dL 34 12 1
1hpG ≥ 155 mg/dL 15 17 1.6 (1.2–2.1)
Waist > 88 cm (female) 383
1hpG < 155 mg/dL 292 33 1
1hpG ≥ 155 mg/dL 91 46 1.6 (1.2–2.1)
Metabolic syndrome 281
1hpG < 155 mg/dL 203 17.1 1
1hpG ≥ 155 mg/dL 78 27.4 1.8 (1.3–2.4)
*Blood pressure ≥ 140/90 mm Hg; OR — odds ratio; CI — confidence interval
Table II. The means of plasma glucose at 0, 30, 60, and 120 minutes (during OGTT) based on one-hour post-load plasma
glucose group in first degree relatives of type 2 diabetics with normal glucose tolerance
Tabela II. Średnie stężenie glukozy w osoczu 0, 30, 60 i 120 minut (podczas doustnego testu obciążenia glukozą) u krewnych
pierwszego stopnia osób chorych na cukrzycę typu 2 w zależności od glikemii 1 godzinę po obciążeniu glukozą
Time (min) 1hpG < 155 mg/dL 1hpG ≥ 155 mg/dL P value
Number 1190 Mean (SD) Number 285 Mean (SD)
0 1190 87 (7.57) 285 90 (6.86) 0.001
30 1143 124 (23.09) 270 154 (25.43) 0.001
60 1190 115 (23.39) 285 175 (17.94) 0.001
120 1189 97 (21.23) 283 110 (21.31) 0.001
1hPG — one-hour plasma glucose
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Our cross-sectional study cannot explain why car-
diovascular risk factors are more prevalent in NGT sub-
jects with elevated 1hPG.
However, to the best of our knowledge, based on
some studies, elevated one-hour plasma glucose level
during OGTT, similar to some other cardiovascular risk
factors, not only increases the risk of future T2DM [8–10]
but also increases cardiovascular mortality and morbid-
ity [6, 15, 16] and all cause mortality in the general pop-
ulation [15, 16].
Therefore, it is suggested that a cohort study be de-
signed to investigate the causal relationship between
elevated 1hPG and cardiovascular risk factors. Our
study is among the few studies which concentrate on
the 1hPG in NGT people. However, none of them have
been carried out on first degree relatives of T2DM.
AUC-G and the mean plasma glucose at 0, 30, 60,
and 120 minutes were significantly higher in the 1hPG
≥ 155 mg/dL NGT group. We can explain these results,
based on the greater prevalence of metabolic syndrome
and decreased early-phase insulin secretion in 1hPG
≥ 155 mg/dL NGT subjects.
In another study, the same results demonstrate de-
fective b-cell function and insulin resistance in 1hPG
≥ 155 mg/dL NGT subjects[17].
Conclusions
The prevalence of most cardiovascular risk factors (but
not low HDL and hypertension) was higher in NGT
subjects with 1hpG ≥ 155 mg/dL. It is recommended
that a cohort study be designed to investigate the caus-
al relationship between cardiovascular risk factors and
increased related mortality in NGT subjects of first de-
gree relatives of T2DM with elevated 1hpG.
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